Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Puretech" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Puretech for you to read. Along with our medical data and news we also list Puretech Clinical Trials, which are updated daily. BioPortfolio also has a large database of Puretech Companies for you to search.
Industry leader brings extensive experience in building and leading clinical development programs for central nervous system disorders Karuna Pharmaceuticals, Inc. (“Karuna”), focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders marked by psychosis and cognitive impairment, today announced the ...
Karuna Pharmaceuticals, an affiliate of UK biopharma PureTech Health, has kicked off a Phase II study of KarXT, which is being developed for the treatment of psychosis in schizophrenia.
Phase 2 study aims to reproduce significant efficacy previously observed in schizophrenia trial with xanomeline alone Company also announces successful Phase 1 study of proprietary xanomeline and trospium chloride co-formulation, which will be used in Phase 2 study Karuna Pharmaceuticals, Inc. (“Karuna”), focused on target...
All doses were safe and well-tolerated VE303 treatment resulted in rapid, durable, dose-dependent colonization and accelerated gut microbiota restoration after antibiotics A Phase 2 study in recurrent C. difficile infection is expected to begin in the fourth quarter of 2018 Three other programs in immuno-oncology, allergy, and in...
Work identifies junction between brain and lymphatics system, offering new insights into disease pathology Novel therapeutic approach to target neuroinflammation enabled by a deeper understanding of pathogenic immune cell trafficking between the CNS and the brain lymphatics Underlying intellectual property is exclusively licensed by PureT...
SummaryPuretech Health plc Puretech, formerly PureTech Ventures LLC is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company offers human proof of concept and pivotal stage programs. It develops a microbiome immune system drugdiscovery platform and drug candidates for immunemediated diseases; and pr...
Developed by leading neuroscientists at the U.C. San Francisco, currently in multiple clinical trials Technology is latest in series of new potential digital treatments Akili is pursuing Akili Interactive (“Akili” or “Company"), a leading prescription digital medicine company developing novel treatments
Research award will support preclinical activities to advance product candidate for the treatment of interstitial cystitis/bladder pain syndrome into the clinic Alivio Therapeutics, an affiliate of
CNS-focused Karuna Pharmaceuticals Inc. (muscarinic receptors for psychiatric and cognitive disorders) raised $42mm in a Seri...
Former Global Head of Immunology at Janssen led development of multiple innovative therapies Vedanta Biosciences, a clinical stage company developing a new category of therapies for immune-mediated and infectious diseases based on rationally defined consortia of human microbiome-derived bacteria, today announced the appointment of industry ...
After many wonderful years at PureTech I am making a transition! Starting September 10 I'll be joining the team at Longwood Fund. I look back with fondness and forward with excitement.
Former Voyager Therapeutics (NASDAQ: VYGR) CEO Steven Paul has been tapped to run Boston-based Karuna Pharmaceuticals, a PureTech Health company that just raised $42 million this month. Karuna is developing a combination schizophrenia treatment that includes xanomeline, a drug it licensed from Eli Lilly (NYSE: LLY), where Paul was once head of R&D.
Former President of Lilly Research Laboratories and Co-founder of Sage and Voyager brings proven track record in neuroscience drug development Karuna founder, Andrew Miller, Ph.D., to serve as Chief Operating Officer Karuna Pharmaceuticals, Inc. (“Karuna”), focused on targeting musc
Akili Interactive (“Akili” or “Company"), a leading prescription digital medicine company developing novel treatments for cognitive dysfunction and brain-related conditions, has raised $13 million in new funding as an extension of its Series C financing, which was announced in May. The additional funds bring the total equity capital Akili has raised ...
Video Analytics Market by Type Software and Services, Application Intrusion Management, Incident Detection, People/Crowd Counting, Traffic Monitoring, Deployment OnPremises and Cloud, Vertical, and Region Global Forecast to 2023 [Report Updated: 03052018
Government investments in emerging technologies to enhance public safety infrastructure and falling prices of video surveillance equipment are expected to drive the video analytics marketThe video analytics market size is expected to grow from USD 3.23 billion in 2018 to USD 8.55 billion by 2023, at a Compound Annual Growth Rate CAGR of 21.5% during the forecast period. Disadvantages of manual vid...
With $42 million in new investment, Karuna Pharmaceuticals, a PureTech Health company based in Boston, now has the funds to test in a Phase 2 clinical trial a drug for a disease where many have previously failed: schizophrenia. Karuna’s lead candidate, KarXT, is a combination of two compounds: xanomeline, licensed from Eli Lilly (NYSE: LLY), […]
Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul MD, and other undisclosed investors
Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul M.D., and other undisclosed investors Karuna Pharmaceuticals, focused on targeting muscarinic receptors for the treatment of disorders marked by psychosis and cognitive impairment, today announced the completion of a $42 million Series A financing round, inc...
Perimeter Intrusion Detection Systems Market by Component Solutions and Services, Solutions Sensors Video Surveillance Systems, Services, Organization Size, Deployment Type, Vertical, and Region Global Forecast to 2023 [Report Updated: 06062018] Prices
Increasing installations of video surveillance for security systems is one of the most significant factors projected to drive the growth of the perimeter intrusion detection systems market.The perimeter intrusion detection systems market is estimated to be USD 10.73 billion in 2018 and is projected to reach USD 21.75 billion by 2023, at a CAGR of 15.2% during the forecast period. This growth can b...
The eleventh annual BioPharm America™ will welcome over 700 global life science executives including pharma, established biotech, startups, and more investors than ever seeking strategic opportunities for new deals advancing
Swiss pharmaceutical giant Roche has signed up to a multi-year collaboration with PureTech Health, a US clinical stage biopharma focused on the brain-immune-gut axis. The partners will advance PureTech’s milk-derived exosome platform technology for the oral administration of Roche’s antisense oligonucleotide platform.
In a multi-year deal, PureTech Health PLC will use its milk-derived exosome platform to develop oral delivery formulations of...